XM does not provide services to residents of the United States of America.
Z
Z

ZurichInsurance

News

Zurich Insurance: Successful Placement Of $500 Mln Of Dated Subordinated Debt

BRIEF-Zurich Insurance: Successful Placement Of $500 Mln Of Dated Subordinated Debt Oct 16 (Reuters) - Zurich Insurance Group AG ZURN.S : ANNOUNCES SUCCESSFUL PLACEMENT OF USD 500 MILLION OF DATED SUBORDINATED DEBT NOTES, WHICH WILL MATURE IN APRIL 2055 AND ARE FIRST CALLABLE IN OCTOBER 2034, WILL BE ISSUED BY ZURICH FINANCE (IRELAND) II DAC ANNUAL
Z

MS favours Italy's Generali among European major insurers

BUZZ-MS favours Italy's Generali among European major insurers ** Morgan Stanley highlights Italy's Generali GASI.MI as its top pick among major European insurance companies, lifting its rating to " o verweight" from "equal-weight" ** It says Generali's capital markets day in January could surprise positively, especially around dividend ** MS forec
A
A
A
Z

Lloyd's of London must stop supporting fossil fuel expansion says NGO

Lloyd's of London must stop supporting fossil fuel expansion says NGO By Virginia Furness LONDON, Oct 9 (Reuters) - The Lloyd's of London SOLYD.UL market is undermining climate action and should impose binding rules to prevent insurers supporting fossil fuel expansion, NGO Reclaim Finance said on Wednesday. Some European insurers, including Generali GASI.MI and Zurich ZURN.S , have imposed restrictions on underwriting for fossil fuel projects in response to pressure from investors and campaigner
L
A
Z

Zurich Insurance to present new three-year plan in Nov

Zurich Insurance to present new three-year plan in Nov ZURICH, Oct 3 (Reuters) - Zurich Insurance ZURN.S will present its new financial targets a year early at an investor day in London on Nov 21, the company said on Thursday. At the meeting, it will unveil and discuss a new three-year plan for 2025 to 2027, a year before the existing cycle, from 2023 to 2025, wraps up, Zurich said.
Z

Bureau Veritas, Covestro AG, Redcare Pharmacy NV

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Covestro AG, Redcare Pharmacy NV Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas, Covestro AG and Redcare Pharmacy NV, on Wednesday. HIGHLIGHTS * British Land BLND.L : Deutsche Bank raises to buy from hold * Bureau Veritas BVI.PA : JP Morgan cuts to neutral from overweight * Covestro AG 1COV.DE : Jefferies cuts to hold from buy * Redcare Pharmacy NV RDC.DE : HSBC raises t
A
A
A
B
B
B
D
E
E
E
E
E
E
E
F
G
I
M
M
A
A
A
A
B
B
E
G
Z

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.